Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	5.04	39.58	37.68
Graham Fair Price	-9.40	19.34	21.35
PEG	71.73	-1.31	0.76
Price/Book	2.56	2.44	2.38
Price/Cash Flow	165.85	125.84	47.33
Prices/Earnings	28.39	24.89	19.39
Price/Sales	2.39	10.94	10.68
Price/FCF	165.85	125.84	47.33
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	-3.29	0.49	0.51
Operating Margin	1.81	0.24	0.24
ROA	-15.59	< 0.005	0.01
ROE	0.03	0.02	-20.12
ROIC	0.02	0.02	3.17
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	-0.01	-0.02	45.67
Dividends QOQ	< 0.005	< 0.005	-25.06
EBIT QOQ	0.09	0.04	-61.41
EPS QOQ	0.25	-0.19	-25.24
FCF QOQ	0.75	-0.61	-18.56
Revenue QOQ	0.03	0.02	-50.45
Naive Interpretation	member

03 - Financial Growth · Bad

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	0.00	0.00	0.00
Days Sales Outstanding (DSO)	56.56	67.48	19.32
Inventory Turnover	0.00	0.00	0.00
Debt/Capitalization	0.51	0.51	-1.27
Quick Ratio	1.03	1.10	6.30
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	25.70	26.05	1.37
Cash	12.15	9.27	-23.76
Capex	-0.28	-0.23	20.27
Free Cash Flow	1.29	0.50	-60.90
Revenue	5.72	5.81	1.53
Naive Interpretation	member

05 - Per Share Metrics · Weak

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	1.07	1.14	6.27
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	7.78	8.89	14.35
Naive Interpretation	Member

06 - Financial Health · Bad

Rating